An update from Barclays ( ($GB:BARC) ) is now available. Barclays PLC has announced the purchase and cancellation of 2,729,311 of its ordinary ...
Barclays PLC (NYSE:BCS) is one of the best UK stocks to buy right now. On September 2, Morgan Stanley analyst Alvaro Serrano maintained a Buy rating on Barclays PLC (NYSE:BCS) and set a price target ...
Barclays Plc has a strong pipeline of deals across its investment and private-banking businesses in Africa as cross-border deal flow picks up and the continent’s largest economy shows signs of ...
Barclays PLC (NYSE:BCS) is one of the best NYSE stocks to buy under $20. On August 5, RBC Capital raised the firm’s price target on Barclays PLC (NYSE:BCS) to 435 GBp from 355 GBp, keeping an ...
Barclays PLC has shown improved financial performance in Q3 2024, but revenue and earnings growth may be challenging due to the expected declining interest rate environment. The bank's valuation ...
An ex-Barclays Plc investment banker, who alleged that an offhand comment taken out of context cost him his job, lost an ...
Barclays (GB:BARC) has released an update. Barclays PLC has recently completed a share buy-back, purchasing 4,626,000 of its own shares to cancel, which will reduce the total issued share capital to ...
A federal judge has dismissed a proposed class action accusing Barclays PLC and its banking unit of violating federal securities laws through the sale of billions of dollars in unregistered structured ...
Good morning. Thank you everybody for coming here and welcome to our Full Year 2023 Results Presentation as well as our Investor Update. You could see the agenda for the day on this slide. And so what ...
Barclays Plc ( (BCS)) has released its Q3 earnings. Here is a breakdown of the information Barclays Plc presented to its investors. Take advantage of TipRanks Premium at 50% off! Unlock powerful ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
On November 20, Barclays raised its price target on Medtronic plc (NYSE:MDT) to $111 from $109 while maintaining an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results